Monitoring bowel habits is particularly important
Virta Health Cuts GLP-1 Use for Weight Loss Over 50% While Driving Significant and Sustained Outcomes, Delivering Major Cost Savings for Payers Revenue Growth Surges to 80% Year-over-Year, Fueled by Demand for Virtas Transformational and Cost-Effective Weight Loss Results Virta Health, a leader in diabetes reversal and sustainable weight loss with a nutrition-first approach, announced early and compelling results from its Sustainable Weight Loss GLP-1 prescribing capabilities, launched earlier this year
Open communication with your healthcare provider is essential for finding a mutually acceptable approach
The most common adverse events were gastrointestinal symptoms (nausea, vomiting, diarrhea, and vomiting)
FibroScan data combined with clinical parameters may increase the diagnostic value and prognostic stratification of MASLD patients (99)
Its too early to share data on how many patients are taking the new triple dose, Novo said